Mean alanine transaminase levels, a marker of NAFLD, were higher in patients with obesity than in those with overweight, but this difference was only significant in female patients (21.9 U/L vs 34.3 U/L, respectively, P=.05). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.